These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 30680469

  • 1. Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer.
    Arvola S, Jambor I, Kuisma A, Kemppainen J, Kajander S, Seppänen M, Noponen T.
    EJNMMI Res; 2019 Jan 24; 9(1):6. PubMed ID: 30680469
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer.
    Kuji I, Yamane T, Seto A, Yasumizu Y, Shirotake S, Oyama M.
    Eur J Hybrid Imaging; 2017 Jan 24; 1(1):2. PubMed ID: 29782587
    [Abstract] [Full Text] [Related]

  • 8. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
    Tabotta F, Jreige M, Schaefer N, Becce F, Prior JO, Nicod Lalonde M.
    BMC Musculoskelet Disord; 2019 Dec 26; 20(1):619. PubMed ID: 31878904
    [Abstract] [Full Text] [Related]

  • 9. Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.
    Bénard F, Harsini S, Wilson D, Zukotynski K, Abikhzer G, Turcotte E, Cossette M, Metser U, Romsa J, Martin M, Mar C, Saad F, Soucy JP, Eigl BJ, Black P, Krauze A, Burrell S, Nichol A, Tardif JC.
    Lancet Oncol; 2022 Dec 26; 23(12):1499-1507. PubMed ID: 36343655
    [Abstract] [Full Text] [Related]

  • 10. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
    An YS, Park DY, Min BH, Lee SJ, Yoon JK.
    BMC Med Imaging; 2021 Mar 26; 21(1):60. PubMed ID: 33771130
    [Abstract] [Full Text] [Related]

  • 11. A Prospective Study Comparing 99mTc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with 18F-Fluoride PET/CT and 18F-Fluoride PET/MRI for Diagnosing Bone Metastases.
    Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM.
    J Nucl Med; 2017 Nov 26; 58(11):1778-1785. PubMed ID: 28798033
    [Abstract] [Full Text] [Related]

  • 12. Skeletal standardized uptake values obtained using quantitative SPECT/CT for the detection of bone metastases in patients with lung adenocarcinoma.
    Lin L, Zheng R, Geng J, Wang X, Li M, Fan R, Zheng Y, Yang K.
    Front Med (Lausanne); 2023 Nov 26; 10():1119214. PubMed ID: 36817798
    [Abstract] [Full Text] [Related]

  • 13. Standardized uptake values of 99mTc-MDP in normal vertebrae assessed using quantitative SPECT/CT for differentiation diagnosis of benign and malignant bone lesions.
    Qi N, Meng Q, You Z, Chen H, Shou Y, Zhao J.
    BMC Med Imaging; 2021 Feb 27; 21(1):39. PubMed ID: 33639883
    [Abstract] [Full Text] [Related]

  • 14. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.
    Oprea-Lager DE, Kramer G, van de Ven PM, van den Eertwegh AJ, van Moorselaar RJ, Schober P, Hoekstra OS, Lammertsma AA, Boellaard R.
    J Nucl Med; 2016 May 27; 57(5):721-7. PubMed ID: 26697964
    [Abstract] [Full Text] [Related]

  • 15. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP.
    Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Hell J Nucl Med; 2017 May 27; 20(3):237-240. PubMed ID: 29177262
    [Abstract] [Full Text] [Related]

  • 16. Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients.
    Letellier A, Johnson AC, Kit NH, Savigny JF, Batalla A, Parienti JJ, Aide N.
    Mol Imaging Biol; 2018 Jun 27; 20(3):482-491. PubMed ID: 29027074
    [Abstract] [Full Text] [Related]

  • 17. Quantitative differences in [(18)F] NaF PET/CT: TOF versus non-TOF measurements.
    Oldan JD, Turkington TG, Choudhury K, Chin BB.
    Am J Nucl Med Mol Imaging; 2015 Jun 27; 5(5):504-14. PubMed ID: 26550541
    [Abstract] [Full Text] [Related]

  • 18. A retrospective study of SPECT/CT scans using SUV measurement of the normal pelvis with Tc-99m methylene diphosphonate.
    Wang R, Duan X, Shen C, Han D, Ma J, Wu H, Xu X, Qin T, Fan Q, Zhang Z, Shi W, Guo Y.
    J Xray Sci Technol; 2018 Jun 27; 26(6):895-908. PubMed ID: 30103368
    [Abstract] [Full Text] [Related]

  • 19. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.
    Pujara AC, Raad RA, Ponzo F, Wassong C, Babb JS, Moy L, Melsaether AN.
    Breast J; 2016 May 27; 22(3):264-73. PubMed ID: 26843433
    [Abstract] [Full Text] [Related]

  • 20. Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients.
    Mohd Rohani MF, Mat Nawi N, Shamim SE, Wan Sohaimi WF, Wan Zainon WMN, Musarudin M, Said MA, Hashim H.
    Ann Nucl Med; 2020 Jan 27; 34(1):39-48. PubMed ID: 31612417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.